Table 2.
Variable | eGFR <90 ml/min/1.73 m2 | OR (95% CI) | p-value |
---|---|---|---|
Median age (Q1;Q3)months |
77 (57;103) |
0.98 (0.97; 0.99) |
<0.001 |
Gender Males |
35 (35.4) |
|
|
Females |
40 (33.9) |
0.94 (0.54; 1.64) |
0.822 |
WAZ ≥−2 |
36 (55) |
|
|
<−2 |
39 (40) |
1.57(0.86; 2.87) |
0.116 |
Diastolic Blood Pressure |
|
|
|
Normal |
61(32.3) |
|
|
Low |
5 (45.5) |
1.75 (0.51; 5.95) |
0.371 |
High |
8 (57.1) |
2.80 (0.93; 8.42) |
0.067 |
Clinical stages |
|
|
|
Stage 1-3 |
58 (31.2) |
|
|
Stage 4 |
17 (54.8) |
2.68 (1.24; 5.80) |
0.012 |
Immunological stage |
|
|
|
Not significant |
29 (36.3) |
|
|
Mild |
12 (35.3) |
0.96 (0.42; 2.22) |
0.922 |
Advanced |
7 (20.0) |
0.44 (0.17; 1.13) |
0.088 |
Severe | 20 (43.5) | 1.35 (0.65; 2.84) | 0.424 |
*3 children did not have serum creatinine results and eGFR was not calculated.
Logistic regression done, odds ratios presented.